PHARMACY

US Bioservices receives Specialty Pharmacy Accreditation

BY Michael Johnsen

VALLEY FORGE, Pa. — US Bioservices, the specialty pharmacy of AmerisourceBergen, on Monday announced that it had received the Specialty Pharmacy Accreditation from URAC, a Washington-based healthcare accrediting organization that establishes quality standards for the healthcare industry.

“US Bioservices’ specialty pharmacy services is focused on helping to positively impact patients’ lives through clinically focused, patient-centric disease and therapy management programs,” stated Craig Miller, US Bioservices’ president. “Our URAC accreditation is a validation of our commitment to quality and accountability in patient care.”

As an independent specialty pharmacy licensed in all states, US Bioservices administers specialty medications, educates patients and provides clinical support to help increase patient compliance to prescribed treatments.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA approves Mylan hypertension drug

BY Alaric DeArment

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug for treating high blood pressure made by Mylan, FDA records showed.

The FDA approved Mylan’s metoprolol succinate tablets in the 25-mg, 50-mg, 100-mg and 200-mg strengths.

The drug is a generic version of AstraZeneca’s Toprol-XL.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

FDA approves new labeling for ViroPharma’s Vancocin

BY Alaric DeArment

EXTON, Pa. — ViroPharma has received approval for updated labeling to its antibiotic drug.

The drug maker announced that the Food and Drug Administration approved the "modernization" of labeling for Vancocin (vancomycin hydrochloride) capsules. The new label includes clinical safety and efficacy data for the drug in treatment strains of Clostridium difficile bacteria currency circulating.

"This new label provides physicians a better understanding about how to treat and monitor patients suffering from the serious and often life-threatening infections that require oral Vancocin therapy," ViroPharma president and CEO Vincent Milano said.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?